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We recently reported that maternal antibiotic treatment (MAT) of mice in the last days of 
pregnancy and during lactation dramatically alters the density and composition of the 
gastrointestinal microbiota of their infants. MAT infants also exhibited enhanced suscep-
tibility to a systemic viral infection and altered adaptive immune cell activation phenotype 
and function. CD8+ effector T cells from MAT infants consistently demonstrate an inability 
to sustain interferon gamma (IFN-γ) production in vivo following vaccinia virus infection 
and in vitro upon T cell receptor (TCR) stimulation. We hypothesize that T cells devel-
oping in infant mice with gastrointestinal microbiota dysbiosis and insufficient toll-like 
receptor (TLR) exposure alters immune responsiveness associated with intrinsic T cell 
defects in the TCR signaling pathway and compromised T  cell effector function. To 
evaluate this, splenic T cells from day of life 15 MAT infant mice were stimulated in vitro 
with anti-CD3 and anti-CD28 antibodies prior to examining the expression of ZAP-70, 
phosphorylated ZAP-70, phospho-Erk-1/2, c-Rel, total protein tyrosine phosphorylation, 
and IFN-γ production. We determine that MAT infant CD8+ T cells fail to sustain total 
protein tyrosine phosphorylation and Erk1/2 activation. Lipopolysaccharide treatment 
in vitro and in vivo, partially restored IFN-γ production in MAT effector CD8+ T cells and 
reduced mortality typically observed in MAT mice following systemic viral infection. Our 
results demonstrate a surprising dependence on the gastrointestinal microbiome and 
TLR ligand stimulation toward shaping optimal CD8+ T cell function during infancy.
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inTrODUcTiOn
Experimental studies continue to offer robust evidence that the gastrointestinal microbiome (GIM) 
exerts a major influence on anatomic and cellular development of the immune system and function 
(1–3). Colonization of the intestine by specific bacteria stabilizes immune regulatory cell populations 
implicated in maintaining health. For example, Th1/Th2 balance (4), Th17 (5), Treg (6), and mucosal 
iNKT cells (7) have been shown to require the GIM for their normal development and function. 
Thus, disrupting the natural progress of intestinal colonization that occurs in the infant GIM may 
Abbreviations: GIM, gastrointestinal microbiome; TCR, T  cell receptor; ERK, extracellular signal-regulated kinase; LPS, 
lipopolysaccharide; TLR, toll-like receptor; PMA, phorbol 12-myristate 13-acetate.
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have both immediate and long-lasting immune consequences. 
Aggressive standards of hygiene, antibiotic use, and malnutri-
tion cause significant short- and long-term disruption on the 
assembly and maturation of the infant GIM (8, 9). We are now 
appreciating that the immune effects of GIM dysbiosis may not 
be realized in the short term. There are emerging high quality 
studies that implicate early-life antibiotic use with the enhanced 
risk of developing allergic and autoimmune diseases later in life 
(10–14). However, the corresponding impact of GIM dysbiosis 
on specific parameters of infant T  cell function has not been 
extensively assessed.
The GIM of infants is particularly vulnerable due to its inherent 
instability and lower species diversity in comparison with older 
children and adults (15, 16). Antibiotics are the most commonly 
prescribed medication in pregnant woman and children and thus 
a leading cause of intestinal dysbiosis. Up to 40% of pregnant 
women are treated with antibiotics during the perinatal period 
(17, 18) and up to 75% of children have been treated with at least 
one course of antibiotics before the age of 2 (19, 20). The most 
common antibiotic treatment of pregnant women is during labor 
with intrapartum antibiotic prophylaxis (IAP) to prevent peri-
natal group B streptococcal (GBS) disease in infants. Penicillin, 
ampicillin, vancomycin, or clindamycin are common antibiotics 
used to treat GBS-colonized mothers during labor (21). Several 
studies have detailed the long-term impact of even short courses 
of antibiotics on the density, complexity, and stability of the GIM 
(22, 23). The effect of maternal intrapartum antibiotics on the 
infant GIM has been detailed in a handful of studies and using a 
culture and non-culture based techniques (24–27). To our knowl-
edge, no studies have evaluated how IAP induced dysbiosis of the 
infant GIM can alter the function of individual adaptive cellular 
immune subsets following birth.
Infants are characterized by a distinct GIM. Therefore, the 
functional behavior and phenotype of infant immune effectors 
may not be regulated by the GIM in the same way as has been 
demonstrated in adults. Infant T cells are compromised in their 
capacity to regulate interferon gamma (IFN-γ), an important 
mediator in controlling viral and other intracellular pathogen 
infections. As demonstrated in mice and humans, infant T cells 
are capable of producing IFN-γ in response to infection, but this 
may be skewed in timing (too early) and in magnitude (too weak) 
as compared to adult T  cells (28). These developmental differ-
ences may be modulated by intrinsic or extrinsic mechanisms and 
include epigenetic hypermethylation of the IFN-γ promoter (29), 
increased T  cell receptor (TCR) activation threshold regulated 
by miRNA (30), inhibition by Tregs (31), skew toward innate 
functional profile (32), insufficient facilitation by infant antigen-
presenting cells (33), or by metabolites of the GIM (34, 35).
We have demonstrated that infant mice with GIM dysbiosis 
caused by maternal antibiotic treatment (MAT) in the last days 
of pregnancy confer increased susceptibility to death following a 
systemic viral infection (36). We observe that CD8+ effector T cells 
from MAT infant mice consistently demonstrate the inability to 
sustain IFN-γ production in vivo following vaccinia virus infec-
tion and in vitro upon TCR stimulation. The goals of this study 
were to further evaluate the intrinsic functional capacity of MAT 
CD8+ T cells and assess proximal and distal signaling molecule 
activation following TCR engagement. We further determined 
whether transfer of MAT CD8+ T cells into a non-dysbiotic host 
environment or stimulation with lipopolysaccharide (LPS) was 
sufficient to rescue signal activation and IFN-γ responsiveness of 
MAT CD8+ T cells.
MaTerials anD MeThODs
Mice
All animal studies were conducted in compliance with an animal 
protocol approved by the Institutional Animal Care and Use 
Committee of Columbia University Medical Center. Six- to 
eight-week-old C57BL/6J, OT-I CD45.1, Rag1KO (B6.129S7-
Rag1tm1Mom/J), MyD88KO [B6.129P2(SLJ)-Myd88tm1.1Def/J], and 
TLR4KO (B6.B10ScN-Tlr4lps-del/JthJ) mice were housed for at 
least 7 days prior to breeding and were maintained under spe-
cific pathogen-free BSL-1 and BSL-2 conditions in Columbia 
University Medical Center animal facilities. Breeding pairs were 
set up in harem, two females and one male per cage. Pregnant 
females were separated from males and single housed at day 17 
postmating. Mice transferred between facilities were allowed to 
acclimate for ≥1  week prior to initiation of experiments. OT-I 
CD45.1 mice were derived by crossing OT-I [C57BL/6-Tg 
(TcrαTcrβ)1100Mjb/J] and CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) 
mice for more than 10 generations. Phenotype of OT-I CD45.1 
mice was confirmed by flow cytometry with antibodies specific 
for CD45.1 (clone A20), CD8α (clone 53-6.7), TCR Vα2 (clone 
B20.1) and TCR V5.1 (clone MR9-4), all from BioLegend (San 
Diego, CA, USA). All parental strains were obtained from the 
Jackson Laboratory (Bar Harbor, ME, USA). Female and male 
pre-weaning littermates were used in all experiments.
Maternal antibiotic Treatment
Pregnant mothers were allowed to drink antibiotic-treated water 
containing a cocktail of ampicillin (AuroMedics), streptomycin 
(X-Gen Pharmaceuticals), and clindamycin (Aurobindo Pharma) 
mixed in sterile water (each at 1 mg/ml) ad libitum 3–5 days prior 
to birth of a litter and for the duration of the experiments. The 
antibiotic-treated water was replaced every 3 days. We previously 
determined that it takes only 3 days to alter the microbiome sig-
nificantly using this cocktail (data not shown) and that refreshing 
the antibiotic solution every 3 days maintains durable depletion 
of the microbiota in adult mice.
T cell isolation and In Vitro activation 
assays
For the in vitro LPS stimulation and OT-I transfer experiments, 
total CD8+ T  cells were purified from gender-matched pooled 
spleens of 15-day-old control (CTRL) and MAT littermate 
C57BL/6J, MyD88KO, TLR4KO, and OT-I mice, respectively, 
using the MojoSort mouse CD8 isolation kit (BioLegend) plus 
biotin anti-CD71 (clone RI7217), biotin anti-CD45R/B220 (clone 
RA3-6B2), and biotin anti-TER119 (clone TER119) followed by 
MACS negative selection (Miltenyi Biotec). CD8+ T cell purity 
routinely yielded 98%. To assess the effect of LPS treatment on 
CD8+ T cell cytokine production, CD8+ T cells were stimulated 
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with plate bound anti-CD3 (1 μg/ml; clone 145-2C11) and solu-
ble anti-CD28 (2 μg/ml; clone 37.51) with or without Escherichia 
coli 055:B5-derived LPS (1 μg/ml; InvivoGen) for 72 h. For the 
TCR signaling assays, total T cells were enriched from individu-
ally processed spleens of 15-day-old CTRL and MAT littermate 
C57BL/6J mice using biotin anti-CD71 (clone RI7217), biotin 
anti-CD45R/B220 (clone RA3-6B2), and biotin anti-TER119 
(clone TER119) followed by MACS negative selection (Miltenyi 
Biotec). To generate effector T cells for TCR signaling assays, total 
T cells (2 × 105 cells/200 μl) were stimulated with plate bound 
anti-CD3 (1  μg/ml; clone 145-2C11) and soluble anti-CD28 
(2 μg/ml; clone 37.51) in RPMI-10 (RPMI 1640 supplemented 
with 10% FBS, 20  mM HEPES, 2  mM l-glutamine, 0.1  mM 
2-mercaptoethanol, 50 μg/ml gentamicin sulfate, 50 U/ml peni-
cillin, and 50 μg/ml streptomycin) in 96 well flat bottom plates 
and incubated at 37°C with 5% CO2 for 24, 48, and 72 h. In some 
TCR signaling assays, purified total CD8+ T cells were used as 
indicated. All antibodies were from BioLegend.
OT-i adoptive cell Transfer experiments
Control and MAT OT-I CD8+ T  cells pooled from littermates 
(1.5 ×  105/100 μl PBS) were transferred into age- and gender-
matched CTRL Rag1KO recipients by intraperitoneal (i.p.) 
injection. Twenty-four hours after OT-I adoptive cell transfer, 
recipient mice were infected i.p. with 1 × 104 PFU of recombi-
nant vaccinia-ovalbumin (Vac-OVA) by i.p. injection. Mice were 
monitored daily for weight loss and appearance of illness. Eight 
days after infection, mice were euthanized by CO2 inhalation. 
Peritoneal exudate cells (PEC) were aspirated following lavage of 
the peritoneum with 1  ml sterile PBS. Spleens and mesenteric 
lymph nodes (MLN) were mechanically disrupted to obtain 
single cell suspensions and then treated with ACK buffer to lyse 
red blood cells. For the detection of cytokines, the cells were 
cultured for 5 h in RPMI-10 with SIINFEKL peptide (5 μM; New 
England Peptide) in the presence of brefeldin A and monensin 
(BioLegend).
In Vivo lPs Treatment and Vac-OVa 
infection
Fifteen-day-old CTRL and MAT C57BL/6J infant mice were 
infected with Vac-OVA (1 × 104 PFU i.p.) and orally treated with 
E. coli 0111:B4-derived LPS (50 μg orogastric; InvivoGen) begin-
ning on the day of the infection and continuing every other day 
for 10 days. Mice were monitored daily for weight loss and appear-
ance of illness. Eleven days after infection, mice were euthanized 
by CO2 inhalation. Spleens were mechanically disrupted to obtain 
single cell suspensions and then treated with ACK buffer to lyse 
red blood cells. For the detection of cytokines, the splenocytes 
were cultured for 5 h in RPMI-10 with SIINFEKL peptide (5 μM; 
New England Peptide), phorbol 12-myristate 13-acetate (PMA) 
(10 ng/ml), and ionomycin (1 μg/ml) in the presence of brefeldin 
A and monensin (BioLegend).
Flow cytometry
Single cell suspensions of lymphocytes isolated from the spleen, 
MLN, or PEC of uninfected and infected infant mice were 
stained with optimal concentrations of the following antibodies 
and reagents: CD3ε (clone 145-2C11), CD8α (clone 53-6.7), 
CD25 (clone PC61), CD44 (clone IM7), CD62L (clone MEL-
14), CD69 (Clone H1.2F3), TNF-α (clone MP6-XT22), IFN-γ 
(clone XMG1.2), pTyr (clone pY20), ZAP-70 (clone 1E7.2), 
phosphorylated ZAP-70 (pZAP-70) Tyr319 (clone n3kobu5; 
eBioscience), Erk2 (clone REA186; Miltenyi Biotec), phospho-
Erk-1/2 (pErk1/2) Thr202/Tyr 204 (clone 4B11B69), c-Rel (clone 
REA397; Miltenyi Biotec), Ki-67 (clone B56; BD Biosciences), 
annexin V, and 7-aminoactinomycin D (7-AAD). All antibodies 
and reagents were from BioLegend unless otherwise specified. 
Dead cells were excluded from the analysis by staining with 
Zombie Aqua (BioLegend). Cells were analyzed on a Fortessa 
flow cytometer (Becton Dickinson) using CellQuest™ software. 
Data were analyzed using FlowJo v10 analysis software (TreeStar).
Tcr signaling analysis by Flow cytometry
Infant CTRL and MAT T  cells (5 ×  105  cells/50 μl) that were 
freshly isolated (unstimulated) or stimulated with anti-CD3/
anti-CD28 for 24, 48, and 72 h were incubated with or without 
soluble anti-CD3 (10  μg/ml; clone 145-2C11; BioLegend) and 
soluble anti-CD28 (10 μg/ml; clone 37.51, BioLegend) in cold 
RPMI 1640 supplemented with 0.5% FBS in 96 well round bottom 
plates at 4°C for 15 min, washed with cold medium, incubated 
with or without soluble goat anti-hamster IgG (20 μg/ml; Jackson 
ImmunoResearch Laboratories) at 4°C for 15 min, washed with 
cold medium, then resuspended in 50 μl of medium and incubated 
in a 37°C water bath for 2 min. After CD3/CD28 crosslinking, cells 
were immediately fixed with 50 μl of pre-warmed Cytofix buffer 
(BD Biosciences) for Erk2 and pErk1/2 staining or IC Fixation 
buffer (eBioscience) for ZAP-70, pZAP-70, pTyr, and c-Rel 
staining, incubated at 37°C for 10 min, and washed with FACS 
buffer (HBSS containing 1% FBS and 0.1% sodium azide) prior 
to staining with antibodies for CD8α, CD44, and CD62L at 4°C 
for 30 min. For intracellular staining of Erk2 and pErk1/2, cells 
were permeabilized with pre-chilled Phosflow Perm III buffer 
(BD Biosciences). For intracellular staining of ZAP-70, pZAP-70, 
pTyr and c-Rel, cells were permeabilized with Perm Wash buffer 
(BioLegend). Cells were incubated with intracellular antibodies 
at 4°C overnight, washed with Perm Wash buffer and then FACS 
buffer prior to analysis. Analysis was performed gating on naïve 
(CD44−) or effector (CD44+) CD8+ T cells as indicated.
statistical analysis
Statistical analysis was performed using GraphPad Prism 7.0. Data 
were analyzed by one-way ANOVA with Holm–Sidak posttest or 
unpaired two-tailed Student’s t-test as indicated. In all analyses, 
values with p < 0.05 were considered statistically significant.
resUlTs
MaT effector cD8+ T cells exhibit less 
Polyfunctional cytokine responses than 
cTrl cells
We recently reported that infant mice whose mothers were 
treated with antibiotics (MAT) in the last days of pregnancy and 
during lactation have significantly altered composition of the 
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GIM, enhanced susceptibility to systemic viral infection, altered 
innate immune cell populations, and poor effector CD8+ T cell 
responses compared with CTRL infants (36). Particularly, MAT 
effector CD8+ T  cells are unable to sustain IFN-γ production 
in vivo following vaccinia virus infection and in vitro upon TCR 
and CD28 stimulation (36). These findings led us to hypothesize 
that the dysfunction observed in MAT CD8+ T cells was due to 
intrinsic cell defects.
To address the fate of MAT and CTRL antigen-specific CD8+ 
T  cells, we adoptively transferred ovalbumin antigen-specific 
CD8+ T cells into a host with a normal GIM prior to challenge 
with a systemic viral infection. Rag1KO mice do not maintain 
endogenous B or T  cells, although subsets of innate immune 
cells are preserved (37), allowing for the evaluation of expansion 
and function of transferred ovalbumin specific OT-I T  cells in 
response to infection. In these experiments, 1.5 × 105 splenic OT-I 
CD8+ T cells isolated from day of life (dol) 15 congenic (CD45.1) 
MAT and CTRL infant mice were adoptively transferred into 
age- and gender-matched CTRL Rag1KO mice. Within 24  h, 
before significant homeostatic proliferation of transferred cells 
can occur (38), mice were infected with Vac-OVA (1 × 104 PFU 
i.p.). At day of infection (doi) 8, which corresponds with the peak 
of the systemic adaptive immune response against vaccinia, we 
isolated lymphocytes from the site of infection in the peritoneum 
and from systemic draining lymphoid tissues (39). We detected 
equivalent percentages of MAT and CTRL OT-I CD8+ T  cells 
(CD45.1+TCRVβ5+) in the PEC, MLN, and spleen of recipient 
mice (Figure  1A). Equivalent percentages of MAT and CTRL 
OT-I effector T cells (CD44+CD62L−) were detected at the site of 
the infection (PEC) and spleen. However, a significantly reduced 
percentage of MAT OT-I effectors was detected in the MLN of 
recipient mice (Figure 1B). Next, we analyzed the expression of 
the activation marker CD69 in MAT and CTRL OT-I effector 
T cells distributed in the spleen, MLN, and PEC of recipient mice. 
We detected similar percentages of CD69+ MAT and CTRL OT-I 
effector T cells at each site (Figure 1C). Nevertheless, based on 
the levels of expression of CD69, MAT OT-I effectors were less 
activated than CTRL effectors but only in the MLN (Figure 1D). 
Finally, we assessed the capacity of MAT and CTRL OT-I T cells 
isolated from the spleen, MLN, and PEC of Vac-OVA-infected 
CTRL Rag1KO recipient mice to produce the effector cytokines 
IFN-γ and TNF-α in response to the MHC class I-restricted 
OVA peptide SIINFEKL. Polyfunctional CD8+ T  cell effectors 
are generated following vaccinia virus infection (40) and are also 
associated with better CTRL of viral infections (41, 42). Both 
MAT and CTRL OT-I effector T  cells had similar percentages 
of IFN-γ- and TNF-α-producing cells at the site of the infection 
(PEC) (Figure 1E). While MAT OT-I effectors exhibited robust 
IFN-γ responses in peripheral lymphoid organs, CTRL OT-I 
effector T cells isolated in the peripheral lymphoid tissues (spleen 
and MLN) were characterized by a high frequency of IFN-γ and 
TNF-α dual producing cells (spleen 58% and MLN 61%). MAT 
OT-I effector T cells had a low frequency of this dual produc-
ing subset (spleen 39% and MLN 30%) and a notably higher 
frequency of non-cytokine producing cells (spleen 19% and 
MLN 20%; Figure  1E). These results illustrate that Ag-specific 
CD8+ T  cells derived from MAT mice despite initial priming 
in a normal microbiota environment under optimal activation 
conditions, overall maintain a differential phenotype from CTRL 
Ag-specific CD8+ T cells in exhibiting decreased polyfunctional 
antiviral cytokine responses. This behavior is consistent with the 
hypothesis that intrinsic differences in MAT infant CD8+ T cells 
exist (36) possibly imprinted by their development in a GIM-
depleted environment.
naïve MaT cD8+ T cells exhibit altered 
Tcr signaling
We previously observed that MAT and CTRL effector CD8+ T cells 
generated in  vitro following TCR and CD28 stimulation had a 
similar frequency of IFN-γ-producing cells at 24 h post-stimula-
tion but MAT effector cells failed to sustain IFN-γ production by 
72 h post-stimulation (36). TCR and CD28 engagement initiates 
intracellular signaling pathways that result in the activation of 
transcription factors that promote the activation, proliferation, 
differentiation, cytokine production, and survival of T cells (43). 
The mitogen-activated protein kinase (MAPK) and the nuclear 
factor-κB (NF-κB) signaling pathways are critical for T cell IFN-γ 
production (44–49). We hypothesized that the impaired IFN-γ 
production in MAT effector CD8+ T  cells results from altered 
TCR-mediated signaling. Accordingly, we analyzed the expres-
sion and activation of proximal and distal proteins involved in 
TCR signaling, including the CD8 alpha chain (CD8α), the TCR 
beta chain (TCRβ), the proximal protein tyrosine kinase ZAP-70, 
the MAPKs Erk1/2, and the member of the NF-κB family of tran-
scription factors, c-Rel. We surmised that intrinsic cell defects in 
MAT CD8+ T cells could occur in naïve cells or later during their 
effector stage. It has been described that TCR-mediated signal-
ing responses differ between naïve, effector, and memory CD8+ 
T cell subsets (50, 51). Therefore, we enriched total T cells from 
the spleens of uninfected dol 15 MAT and CTRL infant mice to 
analyze TCR-mediated signaling in naïve and in vitro generated 
effector CD8+ T cells using flow cytometry.
First, we analyzed CD8α and TCRβ expression in MAT and 
CTRL naïve CD8+ T  cells. We noted equivalent expression of 
these cell surface proteins in both groups (Figures 2A,B). Next, 
we analyzed the expression of the proximal TCR signaling 
molecule ZAP-70. Despite reduced protein expression levels in 
MAT naïve CD8+ T cells (Figure 2C), both MAT and CTRL cells 
exhibited equivalent expression levels of pZAP-70 following TCR 
and CD28 crosslinking (Figure 2D). Moreover, H2O2 stimulation, 
which bypasses TCR stimulation and induces ZAP-70 tyrosine 
phosphorylation (52), resulted in equivalent activation of ZAP-70 
in MAT and CTRL naïve CD8+ T cells (Figure 2D). However, 
unstimulated MAT naïve CD8+ T  cells exhibited an increased 
pZAP-70/ZAP-70 ratio compared with CTRLs (Figure  2E). 
Collectively, these results indicated that proximal TCR-mediated 
signaling capacity is intact in MAT naïve CD8+ T cells and that 
ZAP-70 may be hyper-phosphorylated in these cells.
We then evaluated distal signaling components of the TCR 
signaling pathway, specifically focusing on the MAPK pathway 
regulated by Erk1/2, since its activation is critical for T cell activa-
tion and differentiation (53). MAT and CTRL naïve CD8+ T cells 
displayed similar expression levels of Erk2 (Figure  3A) and 
FigUre 1 | Maternal antibiotic treatment (MaT) effector cD8+ T cells exhibit less polyfunctional cytokine responses than control (cTrl) effector 
cells. Congenic (CD454.1) OT-I CD8+ T cells isolated from the spleens of day of life 15 CTRL and MAT infant mice were adoptively transferred into age- and 
gender-matched CTRL Rag1KO recipient mice 24 h prior vaccinia-OVA infection (1 × 104 PFU intraperitoneal). Lymphocytes isolated from the spleen, mesenteric 
lymph nodes (MLN), and peritoneal exudate cells (PEC) of CTRL Rag1KO recipient mice were analyzed for (a) percentage of CD45.1 and T cell receptor (TCR) Vβ5+ 
cells of total lymphocytes, (B) percentage of CD44+ and CD62L− cells (T effector cells, Teff) of OT-I CD8+ T cells, (c) percentage of CD69+ cells of OT-I Teff cells, (D) 
median fluorescence intensity (MFI) of CD69 of OT-I Teff cells, and (e) percentage of interferon gamma (IFN-γ)- and TNF-α-expressing OT-I Teff cells following in vitro 
stimulation with SIINFEKL peptide (5 μM). DN, double negative for IFN-γ and TNF-α expression. Collated data from two independent experiments are shown (CTRL, 
n = 7; MAT, n = 10). Data in panels (a–c) are presented as mean + SEM. *p < 0.05, unpaired two-tailed Student’s t-test.
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following TCR/CD28 crosslinking, equal percentages (Figure 3B) 
and expression levels of pErk1/2 (Figure 3C). In order to deter-
mine if protein kinase C (PKC) signaling upstream of the Erk1/2 
MAPK pathway was equivalent in MAT and CTRL naïve CD8+ 
T cells, we bypassed TCR signaling by activating T cells with a 
combination of the phorbol ester PMA and the calcium ionophore 
ionomycin. PMA induces PKC auto-phosphorylation by mim-
icking the natural ligand diacylglycerol and ionomycin synergizes 
with PMA (54). We determined that MAT naïve CD8+ T  cells 
had reduced frequency and expression levels of pErk1/2 upon 
FigUre 2 | Maternal antibiotic treatment (MaT) and control (cTrl) naïve cD8+ T cells display equivalent proximal T cell receptor (Tcr)-mediated 
signaling. Total T cells enriched from the spleens of day of life 15 CTRL and MAT infant mice were analyzed for expression of (a) CD8α (CTRL, n = 7; MAT, n = 5), 
(B) TCRβ (CTRL, n = 13; MAT, n = 13), (c) ZAP-70 (CTRL, n = 11, MAT, n = 8), and (D) phospho-ZAP-70 (pZAP-70) (CTRL, n = 6; MAT, n = 3) gating on naïve 
(CD44−) CD8+ T cells by flow cytometry. To analyze pZAP-70 expression (D), the T cells were left unstimulated (−) or stimulated (+) with anti-CD3/anti-CD28 or H2O2 
for 2 min at 37°C. (e) Ratio of pZAP-70/ZAP-70 in unstimulated naïve CD8+ T cells (CTRL, n = 6; MAT, n = 3). Representative graphs (CTRL, white; MAT, black; 
dashed line, negative staining control) and analysis of the median fluorescence intensity (MFI) are shown. Data are representative of two independent experiments 
and presented as mean + SEM. **p < 0.01, unpaired two-tailed Student’s t-test.
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PMA and ionomycin stimulation, suggesting that the activation 
of PKC and Ca2+ mobilization may be somewhat compromised 
in these cells (Figures 3B,C). Finally, we analyzed the expression 
of c-Rel, a component of the NF-κB signal transduction pathway, 
in MAT and CTRL naïve CD8+ T  cells. Its expression levels 
were significantly reduced in MAT cells compared with CTRLs 
(Figure 3D). Collectively, our results demonstrate that although 
MAT and CTRL naïve CD8+ T cells display equivalent proximal 
TCR-mediated signaling, distal- and calcium-dependent signal-
ing events could be compromised.
effector MaT cD8+ T cells Do not sustain 
erk1/2 Phosphorylation
In order to generate effector CD8+ T  cells, we purified CD8+ 
T cells from gender-matched pooled spleens of dol 15 CTRL and 
MAT infant mice, and stimulated CD8+ T cells with anti-CD3 and 
anti-CD28 for up to 72 h. At this point, the CD8+ T cells acquired 
an effector status based on the expression of activation and 
differentiation cell surface markers, proliferation, and cytokine 
production (Figure  4). Both MAT and CTRL CD8+ T  cells 
exhibited equivalent proliferation and differentiation based on 
the expression of Ki-67 and CD44 (Figure 4A). However, despite 
identical frequencies of CD25+ effector cells (Figure  4B), a 
significantly reduced percentage of MAT effector cells produced 
IFN-γ in comparison with CTRL effectors (Figure 4C), consist-
ent with our previous findings. This was not related to differences 
in cell survival since both MAT and CTRL effector CD8+ T cells 
exhibited identical percentages of annexin V and 7-AAD positive 
cells (Figure 4D).
Thus, in order to identify at which time point during effector 
T  cell differentiation, MAT CD8+ T  cells are impaired in their 
capacity to efficiently transduce signals through the TCR to 
sustain IFN-γ production, we analyzed total protein tyrosine 
phosphorylation (pTyr), ZAP-70 expression, and expression/
activation of Erk-1/2 at 24, 48, and 72 h post-stimulation. In these 
assays, we enriched total T cells from the spleens of dol 15 CTRL 
and MAT infant mice, and stimulated T  cells with anti-CD3 
FigUre 3 | Distal T cell receptor-mediated signaling is compromised in maternal antibiotic treatment (MaT) naïve cD8+ T cells. Total T cells enriched 
from the spleens of day of life 15 control (CTRL) and MAT infant mice were analyzed for (a) expression of Erk2 (CTRL, n = 5; MAT, n = 4), (B) percentage of 
phospho-Erk-1/2 (pErk1/2) positive cells (CTRL, n = 5; MAT, n = 4), (c) expression of pErk1/2 (CTRL, n = 5; MAT, n = 4), and (D) expression of c-Rel (CTRL, n = 6; 
MAT, n = 3) gating on naïve (CD44−) CD8+ T cells by flow cytometry. To analyze pErk1/2 expression (B,c), T cells were left unstimulated (−) or stimulated (+) with 
anti-CD3/anti-CD28 or phorbol 12-myristate 13-acetate (PMA)/ionomycin for 2 min at 37°C. Representative graphs (CTRL, white; MAT, black; dashed line, negative 
staining control) and analysis of the median fluorescence intensity (MFI) or percentage are shown. Data are representative of two independent experiments, 
presented as mean + SEM and were analyzed by one-way ANOVA with Holm–Sidak posttest (B,c) or unpaired two-tailed Student’s t-test (D). *p < 0.05, **p < 0.01.
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FigUre 4 | Maternal antibiotic treatment (MaT) and control (cTrl) 
effector cD8+ T cells proliferate and activate equally, but MaT 
effectors produce less interferon gamma (iFn-γ). CD8+ T cells purified 
from pooled spleens of day of life 15 CTRL and MAT infant mice were 
stimulated with anti-CD3/anti-CD28 for 72 h and analyzed for (a) percentage 
of Ki-67 and CD44+ cells, (B) percentage of CD25+ cells of T effector cells 
(CD44+CD62L−, Teff) (CTRL, n = 6; MAT, n = 10), (c) percentage of IFN-γ+ 
Teff cells (CTRL, n = 11; MAT, n = 13), and (D) percentage of 
7-aminoactinomycin D and annexin V positive Teff cells by flow cytometry. 
Data are representative of three independent experiments, presented as 
mean + SEM and were analyzed by unpaired two-tailed Student’s t-test 
(B,c). **p < 0.01.
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and anti-CD28 for the indicated time points. Analysis was then 
performed gating on effector (CD44+) CD8+ T cells. The TCR-
induced total protein tyrosine phosphorylation analysis revealed 
that MAT and CTRL effector CD8+ T cells express similar levels 
of tyrosine phosphorylated proteins at 24  h post-stimulation. 
However, over the course of the subsequent 48 h, these levels were 
markedly reduced in MAT effector CD8+ T cells in comparison 
with CTRL effectors, indicating that TCR-mediated signaling 
events in MAT CD8+ T cells are not sustained during the later 
effector stages (Figure 5A).
ZAP-70 expression in T  cells increases following sustained 
antigenic stimulation, and elevated ZAP-70 protein levels in 
activated CD4+ T cells have been associated with acquisition of 
effector functions (i.e., IFN-γ production) (55). Therefore, we ana-
lyzed ZAP-70 expression in MAT and CTRL effector CD8+ cells at 
48 and 72 h post-stimulation. Although ZAP-70 expression was 
reduced in MAT effector CD8+ T cells at 48 h post-stimulation, its 
expression was equivalently upregulated in both MAT and CTRL 
effector CD8+ T cells by 72 h (Figure 5B). Hence, reduced IFN-γ 
production in MAT effector CD8+ T cells at 72 h post-stimulation 
was not related to impaired ZAP-70 expression (Figure 5C).
Given the similarity in ZAP-70 expression, we examined 
distal signaling molecules required for cytokine gene transcrip-
tion in effector T cells. We focused our analysis on the Erk-1/2 
signaling pathway and Erk2 given its role in T  cell activation 
and IFN-γ transcription (46, 47). At 24 h post-stimulation, we 
detected similar frequency and expression levels of Erk2 in MAT 
and CTRL effector CD8+ T cells (Figures 6A,B). In addition, we 
determined that MAT and CTRL effector CD8+ T cells displayed 
equivalent percentages and expression levels of pErk1/2 follow-
ing TCR and CD28 crosslinking (Figures  6C,D). However, as 
early as 48 and 2 h post-stimulation, MAT effector CD8+ T cells 
displayed significantly reduced frequency and expression levels 
of pErk1/2 compared with CTRL effector cells (Figures 6C,D). 
Although the percentage of Erk2-expressing MAT and CTRL 
CD8+ T  cells remained equivalent at 48 and 72  h post-stimu-
lation (Figure  6A), MAT effector cells expressed significantly 
lower amounts of Erk2 at these time points (Figure  6B). 
Closer analysis revealed that this was due to bimodal expres-
sion of Erk2 in MAT effector cells. As shown in Figure 6E, the 
majority of MAT effector CD8+ T cells expressed intermediate 
to low levels of Erk2 whereas most CTRL effectors expressed 
high levels of this protein at 48  h post-stimulation. Moreover, 
while both Erk2lo- and Erk2hi-expressing CTRL effector CD8+ 
T cells had phosphorylated Erk-1/2, only Erk2hi-expressing MAT 
effector CD8+ T cells had phosphorylated Erk-1/2 at 48 h post-
stimulation (Figure 6E). Furthermore, by 72 h post-stimulation, 
both Erk2lo- and Erkhi-expressing MAT effector CD8+ T  cells 
lacked phosphorylated Erk-1/2 while CTRL effector CD8+ 
T cells retained Erk2 expression and sustained phosphorylation 
of Erk-1/2 (Figure S1 in Supplementary Material). Moreover, we 
observed the exact Erk2 and pErk1/2 expression pattern in MAT 
effector CD8+ T  cells generated upon stimulation of purified 
CD8+ T cells with anti-CD3 and anti-CD28 for 72 h (Figure S2 
in Supplementary Material). This result suggests a differentially 
regulated control of signaling responsiveness (56) in MAT effec-
tor CD8+ T  cells that may contribute to the lack of sustained 
activation of Erk-1/2 (57).
lPs Treatment enhances iFn-γ Production 
in MaT effector cD8+ cells In Vivo and 
In Vitro
It was shown that LPS treatment could restore impaired T cell 
IFN-γ production in an antibiotic-mediated GIM dysbiosis 
adult mouse model of influenza A virus infection (58). Thus, 
we decided to evaluate if LPS treatment in vivo, as a proxy for 
FigUre 5 | Maternal antibiotic treatment (MaT) effector cD8+ T cells do not sustain total protein tyrosine phosphorylation. Total T cells enriched from 
the spleens of day of life 15 control (CTRL) and MAT infant mice were stimulated with anti-CD3/anti-CD28 for 24, 48, and 72 h and analyzed for (a) expression of 
total protein tyrosine phosphorylation (pTyr) (CTRL, n = 6; MAT, n = 5), (B) expression of ZAP-70 (CTRL, n = 7; MAT, n = 6), and (c) percentage of ZAP-70 and 
interferon gamma (IFN-γ) positive cells gating on effector (CD44+) CD8+ T cells by flow cytometry. Representative graphs (CTRL, white; MAT, black) and analysis of 
the median fluorescence intensity (MFI) are shown. Data are representative of two independent experiments and presented as mean + SEM. *p < 0.05, **p < 0.01, 
***p < 0.001, one-way ANOVA with Holm–Sidak posttest.
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colonization by Gram-negative bacteria that are missing in MAT 
mice (36), could enhance T cell-mediated cytokine production 
and rescue MAT infant mice from dying following systemic viral 
infection. Dol 15 MAT and CTRL infant mice were infected with 
Vac-OVA (1 × 104 PFU i.p.) and treated with E. coli-derived LPS 
(50 μg o.g.) beginning on the day of the infection and continuing 
every other day for 10 days. At doi 11, we analyzed the cytokine 
response of splenic MAT and CTRL effector CD8+ T cells and 
observed that LPS treatment enhanced IFN-γ and TNF-α pro-
duction in MAT effector CD8+ T cells to CTRL levels whereas it 
had a modest effect in CTRL cells (Figure 7A). Moreover, LPS 
treatment significantly increased the survival of MAT infants, 
while untreated animals succumbed at the peak of the viral infec-
tion, 60% of LPS-treated MAT mice survived systemic vaccinia 
virus infection (Figure 7B). We also evaluated the effect of LPS 
treatment on IFN-γ and TNF-α production from MAT splenic 
effector CD8+ T cells generated in vitro. MACS-enriched splenic 
CD8+ T cells were stimulated with anti-CD3/CD28 in the absence 
or presence of E. coli 055:B5-derived LPS (1 μg/ml) for 72 h. The 
purity of CD8+ T cells in these cultures was up to 97% (Figure S3 
in Supplementary Material). Compared with CTRL effector 
CD8+ T  cells, MAT effectors cultured in the absence of LPS 
again demonstrated a reduced percentage of IFN-γ- and TNF-
α-producing cells. Including LPS during stimulation of MAT 
spleen-derived effectors resulted in enhanced IFN-γ production 
and unchanged TNF-α production (Figure  7C). The effect of 
the LPS seemed to be specific as we also performed the same 
assays using CD8+ T cells purified from gender-matched pooled 
spleens of dol 15 MAT and CTRL TLR4KO and MyD88KO infant 
mice. We observed that TLR4KO and MyD88KO MAT effectors 
stimulated in the absence of LPS exhibited reduced percentages 
of IFN-γ- and TNF-α-producing cells than CTRLs, and the addi-
tion of LPS during TCR stimulation did not enhance cytokine 
production profiles in either CTRL or MAT-derived CD8+ T cells 
(Figure 8). These results suggest that in certain circumstances of 
GIM dysbiosis, LPS treatment could represent an effective inter-
vention to restore CD8+ T cell function and enhance resistance 
against viral infections.
DiscUssiOn
A goal of our research is to understand how the gastrointestinal 
microbiome (GIM) influences adaptive antiviral immunity dur-
ing infancy. We have discovered that CD8+ T cells from infants 
born of mothers treated with antibiotics (MAT) exhibit markedly 
diminished IFN-γ responses in contrast to age-matched CTRL 
mice developing with a normal GIM. MAT CD8+ T cell responses 
were depressed both in  vivo following sublethal viral infection 
FigUre 6 | Maternal antibiotic treatment (MaT) effector cD8+ T cells do not sustain phosphorylation of erk-1/2. Total T cells enriched from the spleens 
of day of life 15 control (CTRL) and MAT infant mice were stimulated with anti-CD3/anti-CD28 for 24, 48, and 72 h and analyzed for (a) percentage of Erk2+ cells 
(CTRL, n = 7; MAT, n = 6), (B) expression of Erk2 (CTRL, n = 7; MAT, n = 6), (c) percentage of phospho-Erk-1/2 (pErk1/2) positive cells (CTRL, n = 7; MAT, n = 6), 
and (D) expression of pErk1/2 gating on effector (CD44+) CD8+ T cells (Teff). (e) Percentage of CD8+ Teff cells expressing low or high levels of Erk2 (Erk2lo and Erk2hi, 
respectively) and gating analysis of their corresponding pErk1/2-expressing populations at 48 h post-stimulation. Data are representative of two independent 
experiments and presented as mean + SEM. *p < 0.05, ****p < 0.0001, one-way ANOVA with Holm–Sidak posttest.
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and in  vitro following TCR/CD28 stimulation. The in  vitro 
experiments indicated that MAT infant CD8+ T  cells maintain 
intrinsic cell dysfunction when removed from their host environ-
ment. This intrinsic dysfunction was not fully restored following 
transfer of 15-day-old MAT T  cells into an age-matched non-
dysbiotic host environment or by treatment with E. coli-derived 
LPS. Collectively, our results demonstrate that systemic T cells 
that develop in infant mice with GIM dysbiosis exhibit T  cell 
dysfunction due to altered expression and activation of key TCR 
signaling proteins thus compromising sustained T cell cytokine 
production.
Our results suggest that the dysbiotic environment present 
in infant MAT mice imprints their peripheral CD8+ T cells and 
suppresses intrinsic responsiveness, although the exact mecha-
nism mediating this effect is not yet clear. While infant T cells 
can generate adult-like responses in specific circumstances 
(59), emerging studies of neonatal T  cells from a normal host 
microbiota environment support that intrinsic properties 
distinguish their TCR responsiveness from juvenile and adult 
T cells (60, 61). Human cord blood-derived CD4+ T cells were 
found deficient in TCR-associated signaling molecules includ-
ing low Lck expression, inefficient phosphorylation of Lck, and 
FigUre 7 | lipopolysaccharide (lPs) treatment enhances interferon gamma (iFn-γ) production in maternal antibiotic treatment (MaT) effector cD8+ 
cells in vivo and in vitro. Control (CTRL) and MAT infant mice were infected at day of life (dol) 15 with vaccinia-ovalbumin (Vac-OVA, 1 × 104 PFU intraperitoneal) 
and were treated with Escherichia coli-derived LPS (50 μg o.g.) every other day for 10 days (Vac-OVA + LPS). (a) At day of infection 11, lymphocytes were isolated 
from the spleens of CTRL and MAT mice infant mice and stimulated in vitro with SIINFEKL peptide, phorbol 12-myristate 13-acetate, and ionomycin for 5 h to 
analyze the percentage of IFN-γ- and TNF-α-producing CD8+ T effector cells (CD44+CD62L−, Teff) by flow cytometry (CTRL Vac-OVA, n = 3; CTRL Vac-OVA + LPS, 
n = 7; MAT Vac-OVA, n = 2; MAT Vac-OVA + LPS, n = 3). (B) Survival curve of CTRL and MAT infant mice following Vac-OVA infection and LPS treatment (CTRL 
Vac-OVA, n = 5; CTRL Vac-OVA + LPS, n = 5; MAT Vac-OVA, n = 2; MAT Vac-OVA + LPS, n = 11). Comparison of survival curves was performed by log-rank 
(Mantel–Cox) test. Data are representative of two infection experiments. (c) Pooled CD8+ T cells isolated from the spleens of uninfected dol 15 CTRL (n = 3) and 
MAT (n = 6) infant mice were stimulated with anti-CD3/anti-CD28 with or without Escherichia coli-derived LPS (1 μg/ml) for 72 h and analyzed for the percentage of 
IFN-γ and TNF-α-producing Teff cells by flow cytometry. Data are representative of three independent experiments.
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FigUre 8 | cytokine production of control (cTrl) and maternal antibiotic treatment (MaT) Tlr4KO and MyD88KO effector cD8+ T cells in response 
to lipopolysaccharide (lPs). Pooled CD8+ T cells isolated from the spleens of uninfected day of life 15 CTRL TLR4KO (n = 2), MAT TLR4KO (n = 5), CTRL 
MyD88KO (n = 5), and MAT MyD88KO (n = 4) infant mice were stimulated with anti-CD3 and anti-CD28 with or without Escherichia coli-derived LPS (1 μg/ml) for 
72 h. Analysis of the percentage of interferon gamma (IFN-γ) and TNF-α-producing effector CD8+ T cells (CD44+CD62L−) was performed by flow cytometry. DN, 
double negative for IFN-γ and TNF-α expression. Data are representative of two independent experiments.
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downstream reduced TCR-associated protein expression (62, 63). 
Additionally, cord blood-derived human neonatal CD8+ T cells 
appear to require IL-12 to provide a “third signal” following CD3 
and CD28 stimulation in order to achieve maximal expansion, 
proliferation, IL-2 production, and differentiation into IFN-γ 
producing effector cells (64). In order to achieve the maximal 
phosphorylation of proximal signaling and later stage TCR 
signaling molecules, sustained IL-12 signaling is required for at 
least 72  h. Thus, proximal and distal signaling events may not 
act in concert in infant T  cells modifying their responsiveness 
to TCR-dependent signaling for activation and differentiation. 
We similarly noted differences in the proximal expression and 
downstream sustained phosphorylation in MAT CD8+ T  cells. 
The finding of differential expression of Erk1/2 in MAT effector 
CD8+ T cells was surprising yet the lower expression of Erk1/2 
correlated with diminished and poorly sustained activation in 
these cells. We speculate that this differential expression could 
be due to alternative splice variants or other intrinsic factors 
regulating posttranslational protein stability of Erk1/2 (65) in 
MAT effector CD8+ T cells. Future experiments will be directed to 
evaluate these possibilities. Overall, our results indicate a require-
ment for a numerically dense and diverse GIM in contributing to 
full effector function of infant CD8+ T cells.
In addition to T  cell-signaling differences, infants are also 
characterized by a distinct GIM (66). Therefore, the functional 
behavior and phenotype of infant adaptive T  cell responses 
regulated by the GIM may not be equivalent to adults. In adult 
mice, depleting the microbiota by antibiotics suppressed inflam-
masome activation and expression of antiviral defense genes 
in innate immune cells resulting in poor influenza-specific or 
LCMV-specific T  cell responses (67, 68). However, our results 
indicate that dysbiosis of the infant GIM directly impacts infant 
CD8+ T cells further compromising the already reduced capacity 
of infant T cells to generate sufficient IFN-γ driven responses (28).
We observed an increased pZAP-70/ZAP-70 ratio in unstimu-
lated MAT naïve CD8+ T cells with respect to CTRL cells. There 
is precedence that an altered GIM can effect baseline activation 
of systemic T  cells. Huang et  al. established a restricted flora 
mouse model in which mice are maintained with a limited 
microbiota of defined by six non-pathogenic Clostridium species. 
They observed that adult splenic naïve CD4+ T  cells exhibited 
TCR hyperresponsiveness that was associated with increased 
phosphorylation of the signaling molecules ZAP-70, Lck, and 
LAT, and increased activation induced cell death (69). It is pos-
sible that alterations in TCR-mediated signaling in MAT T cells 
include hyper-phosphorylated basal levels of critical proximal 
and intermediate signaling proteins in order to compensate 
for downstream deficiencies. Just as Huang et  al., we similarly 
speculate that the reduced microbial environment in MAT mice 
either suppresses a baseline state required for T cell functional 
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homeostasis or that circulating metabolites of the microbiome 
regulate differential responsiveness of CD8+ T cells. A reduction 
in the density or diversity of species producing immune regulating 
metabolites could thus impact normal patterns of transcriptional 
and signal regulation in peripheral infant T cells dependent upon 
these products.
The myriad of/and mechanisms by which microbiota-derived 
products mediate immune effects still remains to be fully 
characterized (70, 71). In a recent examination, the capacity of 
inflammatory cytokine production in human peripheral blood 
lymphocytes has been linked to the GIM and specific micro-
bial metabolic pathways (72). In addition, two well described 
examples of microbial-derived factors are shown to regulate 
T  cells in  vivo. PSA produced by Bacteroides fragilis engages 
TLR2 expressed on T  cells to promote Treg differentiation in 
peripheral lymphoid tissues (73). The short-chain fatty acid 
butyrate serves as an energy source for colonic epithelial cells 
but also mediates immune system homeostasis and function by 
binding to GPR43 expressed on a variety of innate and adaptive 
immune cells, specifically Tregs (74). Butyrate is also able to 
direct epigenetic gene modification by acting on HDAC (35). 
Given the importance of epigenetic mechanisms involved in 
regulating development and function of infant T cells (32, 75), 
it is interesting to speculate regarding their permissiveness to 
circulating bacterial metabolites derived from the infant GIM. A 
direct effect of LPS on enriched or purified human and murine 
T cells in vitro has been previously described (76). However, we 
cannot completely rule out that the in vitro effects of LPS CD8+ 
T  cells in our assay were mediated via contaminating innate 
effectors since we did not use sort purified cells. Nonetheless, 
LPS has been successfully used as an adjuvant to enhance 
viral- and vaccine-specific responses in vivo (58, 77), and we did 
observe a positive effect of bacterial-derived LPS on enhancing 
MAT T cell function and MAT infant mouse survival following 
viral infection. The partial response observed in the mice could 
indicate that treatment occurred too late to fully rescue MAT 
functional responses and that specific age windows exist when 
a normal GIM must be present to support the development and 
function of normal immunity.
Infancy and childhood is a period marked by enhanced 
baseline susceptibility to viral infections and is also the period of 
life when the majority of vaccines are given. Thus, an evaluation 
of how GIM dysbiosis during this period of life can alter T cell 
immunity is critical for our understanding of infant immunity in 
general, and for developing strategies that can protect or enhance 
CD8+ T cell immunity. Our results suggest that the infant GIM 
imprints CD8+ T cell function during this period of life and could 
have long-term consequences. Our ongoing and future analysis 
of this model includes (1) determining the long-lasting impact of 
GIM dysbiosis on T cell function, particularly in the generation of 
long-term memory, (2) testing strategies that can be used to cor-
rect the dysfunction, (3) and evaluating the role of infant-derived 
GIM microbial metabolites in regulating CD8+ T  cell antiviral 
immunity.
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